{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:03:30Z","timestamp":1762866210770},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/coc.0b013e31829e19fb","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T00:35:53Z","timestamp":1372898153000},"page":"382-387","source":"Crossref","is-referenced-by-count":26,"title":["Outcome of Adjuvant Therapy in Biliary Tract Cancers"],"prefix":"10.1097","volume":"38","author":[{"given":"Mairead G.","family":"McNamara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitan","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L.","family":"McKeever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trisha","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hedley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Krzyzanowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Gallinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Greig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Knox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210128","first-page":"212","article-title":"Diagnosis and treatment update: cholangiocarcinoma.","volume":"43","author":"Wijaya","year":"2011","journal-title":"Acta Med Indones"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/1098-2388(200009)19:2<145::AID-SSU7>3.0.CO;2-6","article-title":"Gallbladder cancer.","volume":"19","author":"Bartlett","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":". Cancer statistics.","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.soc.2008.12.004","article-title":"Surgical management of gallbladder cancer.","volume":"18","author":"Reddy","year":"2009","journal-title":"Surg Oncol Clin N Am"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":". Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.","volume":"30","author":"Horgan","year":"2012","journal-title":"J Clin Oncol"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":". New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1148\/radiol.2383050419","article-title":". Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria.","volume":"239","author":"Lee","year":"2006","journal-title":"Radiology"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.sla.0000193604.72436.63","article-title":". Anatomic right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma.","volume":"243","author":"Nagino","year":"2006","journal-title":"Ann Surg"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00268-005-0181-z","article-title":". Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancerfrom the perspective of mode of lymph node involvement and surgical outcome.","volume":"30","author":"Sasaki","year":"2006","journal-title":"World J Surg"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","article-title":". Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.","volume":"23","author":"Knox","year":"2005","journal-title":"J Clin Oncol"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":". Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":". Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":". Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma.","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"JAMA"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5858\/133.1.67","article-title":". Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.","volume":"133","author":"Henson","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jso.21374","article-title":". Cancers of the ampulla of vater; demographics, morphology, and survival based on 5625 cases from the SEER program.","volume":"100","author":"Albores-Saavedra","year":"2009","journal-title":"J Surg Oncol"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s10620-005-3040-8","article-title":". Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.","volume":"50","author":"Itoh","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R21-11-20210128","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1245\/s10434-008-9998-7","article-title":". Extrahepatic bile duct adenocarcinoma: patients at high risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone.","volume":"15","author":"Borghero","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":". Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ejso.2005.02.021","article-title":". Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK.","volume":"31","author":"Silva","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":". Cholangiocarcinoma: thirty-one year experience with 564 patients at a single institution.","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00534-006-1194-1","article-title":". Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.","volume":"14","author":"Sano","year":"2007","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R26-11-20210128","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/COC.0b013e318209aa29","article-title":". Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.","volume":"35","author":"Kim","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","article-title":". Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.","volume":"29","author":"Wang","year":"2011","journal-title":"J Clin Oncol"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/1471-2407-11-267","article-title":". Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.","volume":"11","author":"Bonet Beltran","year":"2011","journal-title":"BMC Cancer"},{"key":"R29-11-20210128","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":". Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0b013e31829e19fb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T07:00:09Z","timestamp":1645945209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201508000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31829e19fb","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}